Adjustment of drug therapy and pharmaceutical care for a case of follicular non-Hodgkin lymphoma with persistent coronavirus positivity accompanied by Pneumocystis jirovecii pneumonia
Adjustment of drug therapy and pharmaceutical care for a case of follicular non-Hodgkin lymphoma with persistent coronavirus positivity accompanied by Pneumocystis jirovecii pneumonia
A case of follicular non-Hodgkin lymphoma remained persistently positive for the coronavirus and developed acute respiratory distress syndrome(ARDS)after infection and his viral status did not revert to negative despite multiple courses of antiviral therapy,and meanwhile he experienced decrease in all three blood cell lines and developed secondary complications including Pneumocystis jirovecii pneumonia,bacterial infections and cytomegalovirus infection.Addressing the different stages of prolonged immunosuppression in the host,conflicting treatment strategies were identified.Considering the patient's evolving condition,medication characteristics,timely adjustments to drug therapy and pharmaceutical monitoring were implemented.The patient's overall condition was gradually improved.This case highlights the importance of capturing real-time primary contradictions in complex and evolving medical conditions,dynamically adjusting treatment plans.
关键词
滤泡性非霍奇金淋巴瘤/新型冠状病毒感染/耶氏肺孢子菌肺炎/药物治疗调整/药物监护
Key words
follicular non-Hodgkin lymphoma/COVID-19/Pneumocystis jirovecii pneumonia/drug therapy adjustment/pharmaceutical care
维普
万方数据